Microtubule-Dependent Neuronal Migration Failure Module

The seed review emphasized rodent-versus-human cortical-development differences and the value of iPSC/organoid systems. For curation this should be treated as a human/model mismatch knowledge-gap category: mouse migration evidence can establish conserved mechanisms, but organoids or fetal-human data may be needed to decide whether outer-radial-glia timing, cleavage orientation, or human-specific transcript usage changes the pathograph for a specific disorder.

The Tubulinopathies grouping keeps its members as separate Disease entries on the premise that tubulin isotypes differ in expression timing and binding partners, so an equivalent lesion in a different isotype yields a different malformation. That premise is the load-bearing justification for the split, and until recently it was asserted rather than evidenced. Two independent lines of 2026 work now supply the two halves of a mechanism. First, composition: spatially resolved atlases show tubulin isotype transcripts are not interchangeable across cell states, ranging from broadly expressed (TUBA1A, TUBA1B) to cell-type-restricted, with TUBB3 and TUBG1 enriched in particular lineages. Second, consequence: the isotype-specific C-terminal tails differentially engage motor proteins, with TUBB2A, TUBB2B and TUBB2C altering the conformational motions of the dynein microtubule-binding and stalk domains. Together these predict that which isotype is mutated determines both WHERE and WHEN the lesion is felt and WHICH motor-dependent step degrades. What is still missing is the direct test: no study has taken one substitution to an equivalent structural position across several isotypes in a common cellular background and measured the divergence. Until that exists, isotype specificity remains a well-motivated model rather than a demonstrated explanation, and curators should not attribute a member's distinctive malformation pattern to its isotype as though the causal chain were established.

Human pluripotent-stem-cell-derived three-dimensional cerebral or cortical organoids used to model lissencephaly and microcephaly mechanisms, including live assays of neuronal migration, neuroepithelial apoptosis, cleavage orientation, and outer-radial-glial mitotic behavior.

Pathogenic variation perturbs the microtubule apparatus used by developing neurons and neural progenitors. Representative mechanisms include defective DCX-mediated microtubule stabilization, impaired alpha/beta-tubulin heterodimer formation or MAP binding, gamma-tubulin nucleation defects, altered dynein microtubule binding, and kinesin ATPase/folding defects.

Migrating neurons fail to execute normal microtubule-dependent movement, including leading-process stabilization, nucleokinesis, centrosome-nucleus coupling, and radial migration along radial-glial scaffolds. Depending on the gene and developmental window, the defect can appear as delayed migration, arrested cells in intermediate/subventricular regions, or abnormal neuronal positioning.

The tissue-level effect is abnormal cortical architecture: neurons remain ectopic, the cortical plate is thickened or poorly laminated, and gyral patterning may show lissencephaly, pachygyria, subcortical band heterotopia, or selected polymicrogyria-like malformations. Disorder-specific entries should state the relevant anatomic gradient and whether pial basement membrane failure, progenitor depletion, or another module is also needed.

Optional side branch in which the same microtubule/tubulin apparatus disrupts axon guidance, commissural tract development, or long-range projection maintenance. This branch is important for TUBB3-related phenotypes and some broader tubulin/motor disorders, but its presence should not be assumed for all conforming microtubule-migration entries.